The China Post
Date: March 8, 2017
By: Sun Hsin Hsuan
The Food and Drug Administration (FDA) ordered a recall Tuesday of Taiwan’s most
widely used lipid-lowering drug after more counterfeit versions of the drug were found.
The drug’s maker, pharmaceutical giant AstraZeneca, issued a statement through its Taiwan affiliate on Tuesday announcing a recall of the Crestor (冠脂妥) drug in a joint effort with the FDA.
FDA Director Wu Shou-mei (吳秀梅) said investigators had found counterfeit Crestor drugs with the batch number MK479.
The discovery came after counterfeit Crestor drugs with the batch number MV503 were found on Sunday. [FULL STORY]